Abstract
Epinephrine, in high doses, exhibits cardiotoxicity that is associated with excessive production of free radicals. Melatonin is antioxidant and free radical scavenger with cardioprotective properties. In our study, cardioprotective effects of melatonin against epinephrine cardiotoxicity were explored in the model of isolated rat heart. In the melatonin group, melatonin (50 μmol/l) was present in the perfusion solution during the whole experiment. In the control group, perfusion solution contained no melatonin. In both of the groups, after 30 min of initial perfusion, epinephrine was applied during 2 min directly into the heart and led to its strong stimulation. Changes in the heart function and arrhythmogenesis were evaluated before application of epinephrine and after the decline of its acute effects. No significant differences were observed during the initial perfusion. However, in the 15th and 20th minute after epinephrine application, indexes of ventricular contraction and relaxation were significantly higher in the melatonin group. Likewise, the values of the left ventricular developed pressure were significantly increased in this group in the 15th minute. These differences indicate better preservation of contraction and relaxation in the melatonin-treated group. Parameters of arrhythmogenesis—arrhythmia score, incidence and total duration of severe ventricular arrhythmias, were not significantly different between the experimental groups. However, their markedly lower average values in the melatonin-treated group suggest the reduction of electrical instability by melatonin. In conclusion, the obtained data confirm cardioprotective properties of melatonin and fill in the mosaic of information that can lead to the usage of melatonin as a therapeutic tool.
Similar content being viewed by others
References
Abete P, Bianco S, Calabrese C, Napoli C, Cacciatore F, Ferrara N, Rengo F (1997) Effects of melatonin in isolated rat papillary muscle. FEBS Lett 412:79–85
Acikel M, Buyukokuroglu ME, Aksoy H, Erdogan F, Erol MK (2003) Protective effects of melatonin against myocardial injury induced by isoproterenol in rats. J Pineal Res 35:75–79
Andelová E, Barteková M, Pancza D, Styk J, Ravingerová T (2005) The role of NO in ischemia/reperfusion injury in isolated rat heart. Gen Physiol Biophys 24:411–426
Arvola L, Bertelsen E, Lochner A, Ytrehus K (2006) Sustained anti-beta-adrenergic effect of melatonin in guinea pig heart papillary muscle. Scand Cardiovasc J 40:37–42
Bloom S, Davis DL (1972) Calcium as mediator of isoproterenol-induced myocardial necrosis. Am J Pathol 69:459–470
Buijs RM, van Eden CG, Goncharuk VD, Kalsbeek A (2003) The biological clock tunes the organs of the body: timing by hormones and the autonomic nervous system. J Endocrinol 177:17–26
Dobsak P, Siegelova J, Eicher JC, Jancik J, Svacinova H, Vasku J, Kuchtickova S, Horky M, Wolf JE (2003) Melatonin protects against ischemia-reperfusion injury and inhibits apoptosis in isolated working rat heart. Pathophysiology 9:179–187
Dominguez-Rodriguez A, Abreu-Gonzalez P, Avanzas P (2012) The role of melatonin in acute myocardial infarction. Front Biosci (Landmark Ed) 17:2433–2441
Dominguez-Rodriguez A, Abreu-Gonzalez P, Sanchez-Sanchez JJ, Kaski JC, Reiter RJ (2010) Melatonin and circadian biology in human cardiovascular disease. J Pineal Res 49:14–22
Genade S, Genis A, Ytrehus K, Huisamen B, Lochner A (2008) Melatonin receptor-mediated protection against myocardial ischaemia/reperfusion injury: role of its anti-adrenergic actions. J Pineal Res 45:449–458
Kaneko S, Okumura K, Numaguchi Y, Matsui H, Murase K, Mokuno S, Morishima I, Hira K, Toki Y, Ito T et al (2000) Melatonin scavenges hydroxyl radical and protects isolated rat hearts from ischemic reperfusion injury. Life Sci 67:101–112
Lochner A, Huisamen B, Nduhirabandi F (2013) Cardioprotective effect of melatonin against ischaemia/reperfusion damage. Front Biosci (Elite Ed) 5:305–315
Mukherjee D, Roy SG, Bandyopadhyay A, Chattopadhyay A, Basu A, Mitra E, Ghosh AK, Reiter RJ, Bandyopadhyay D (2010) Melatonin protects against isoproterenol-induced myocardial injury in the rat: antioxidative mechanisms. J Pineal Res 48:251–262
Navarro-Sobrino M, Lorita J, Soley M, Ramírez I (2010) Catecholamine-induced heart injury in mice: differential effects of isoproterenol and phenylephrine. Histol Histopathol 25:589–597
Patel V, Upaganlawar A, Zalawadia R, Balaraman R (2010) Cardioprotective effect of melatonin against isoproterenol induced myocardial infarction in rats: a biochemical, electrocardiographic and histoarchitectural evaluation. Eur J Pharmacol 644:160–168
Paulis L, Pechanova O, Zicha J, Barta A, Gardlik R, Celec P, Kunes J, Simko F (2010) Melatonin interactions with blood pressure and vascular function during L-NAME-induced hypertension. J Pineal Res 48:102–108
Paur H, Wright PT, Sikkel MB, Tranter MH, Mansfield C, O'Gara P, Stuckey DJ, Nikolaev VO, Diakonov I, Pannell L et al (2012) High levels of circulating epinephrine trigger apical cardiodepression in a β2-adrenergic receptor/Gi-dependent manner: a new model of Takotsubo cardiomyopathy. Circulation 126:697–706
Ravingerova T, Tribulova N, Slezak J, Curtis MJ (1995) Brief, intermediate and prolonged ischemia in the isolated crystalloid perfused rat heart: relationship between susceptibility to arrhythmias and degree of ultrastructural injury. J Mol Cell Cardiol 27:1937–1951
Ravingerová T, Tribulová N, Ziegelhöffer A (1993) The late effect of 7-oxo prostacyclin protects the rat heart against calcium paradox. Life Sci 53:1309–1316
Reiter RJ, Tan DX (2003) Melatonin: a novel protective agent against oxidative injury of the ischemic/reperfused heart. Cardiovasc Res 58:10–19
Rona G (1985) Catecholamine cardiotoxicity. J Mol Cell Cardiol 17:291–306
Sahna E, Parlakpinar H, Turkoz Y, Acet A (2005) Protective effects of melatonin on myocardial ischemia/reperfusion induced infarct size and oxidative changes. Physiol Res 54:491–495
Scheer FA, Kalsbeek A, Buijs RM (2003) Cardiovascular control by the suprachiasmatic nucleus: neural and neuroendocrine mechanisms in human and rat. Biol Chem 384:697–709
Simko F, Paulis L (2007) Melatonin as a potential antihypertensive treatment. J Pineal Res 42:319–322
Singal PK, Beamish RE, Dhalla NS (1983) Potential oxidative pathways of catecholamines in the formation of lipid peroxides and genesis of heart disease. Adv Exp Med Biol 161:391–401
Szárszoi O, Asemu G, Vanecek J, Ost'ádal B, Kolár F (2001) Effects of melatonin on ischemia and reperfusion injury of the rat heart. Cardiovasc Drugs Ther 15:251–257
Tan DX, Manchester LC, Reiter RJ, Qi W, Kim SJ, El-Sokkary GH (1998) Ischemia/reperfusion-induced arrhythmias in the isolated rat heart: prevention by melatonin. J Pineal Res 25:184–191
Tengattini S, Reiter RJ, Tan DX, Terron MP, Rodella LF, Rezzani R (2008) Cardiovascular diseases: protective effects of melatonin. J Pineal Res 44:16–25
Vazan R, Janega P, Hojná S, Zicha J, Simko F, Pechánová O, Styk J, Paulis L (2007) The effect of continuous light exposure of rats on cardiac response to ischemia-reperfusion and NO-synthase activity. Physiol Res 56(Suppl 2):S63–S69
Walker MJ, Curtis MJ, Hearse DJ, Campbell RW, Janse MJ, Yellon DM, Cobbe SM, Coker SJ, Harness JB, Harron DW (1988) The Lambeth Conventions: guidelines for the study of arrhythmias in ischaemia infarction, and reperfusion. Cardiovasc Res 22:447–455
Zeman M, Herichova I (2013) Melatonin and clock genes expression in the cardiovascular system. Front Biosci (Schol Ed) 5:743–753
Acknowledgments
This study was supported by grants VEGA SR 2/0201/12 and APVV-0102-11. The authors are grateful to Dipl. Ing. D. Pancza for his excellent technical assistance.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Vazan, R., Ravingerova, T. Protective effect of melatonin against myocardial injury induced by epinephrine. J Physiol Biochem 71, 43–49 (2015). https://doi.org/10.1007/s13105-014-0377-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13105-014-0377-5